当前位置:
首页>产品中心>单抗/多抗>Crizanlizumab ELISA Kit|Crizanlizumab ELISA试剂盒(靶标:)
Crizanlizumab ELISA Kit|Crizanlizumab ELISA试剂盒(靶标:)
- 货号:RB9TDB885018
- 价格:面议
- 点击:433
产品介绍
产品参数
| 应用 | ELISA |
|---|
| 检测方法 | Colorimetric |
|---|
| 灵敏度 | 0.156 μg/ml |
|---|
| 检测范围 | 0.31-5 μg/mL |
|---|
| 回收率 | 80-120% |
|---|
| 样本类型 | Plasma, Serum |
|---|
| 检测类型 | Quantitative |
|---|
| 稳定性和储存 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
|---|
| 运输条件 | 2-8 ℃ |
|---|
| 登录号 | P16109 |
|---|
| 背景信息 | Crizanlizumab is a humanized monoclonal antibody directed against P-selectin that showed effectiveness in preventing VOC induced pain crises. Median rate of pain crises was 1.63 in crizanlizumab treated group versus 2.998 in placebo group. Furthermore, the median time to crisis was 4.07 months with crizanlizumab compared to 1.38 in the placebo group. The benefits of treatment held true within subgroups including those with a high number of VOC prior to treatment and those with more severe genotype. The drug is FDA approved to reduce the frequency of VOC in adults and pediatric patients with SCD aged 16 years and older. |
|---|
| 别名 | SelG1, 1690318-25-2 |
|---|
| 备注 | For Research Use Only. |
|---|
【仅供科学研究使用】
相关产品: